Form 4: Turtle Beach Corp Director Andrew Wolfe Reports Acquisition of Common Stock

Sentiment:

SEC Form 4 Filing


Director Andrew Wolfe acquired 1,992 shares of Turtle Beach Corp common stock on May 3, 2024, as part of compensation for services on the Value Enhancement Committee.

Summary

  • On May 3, 2024, Andrew Wolfe, a director of Turtle Beach Corp, acquired 1,992 shares of common stock.
  • The acquisition was a grant of restricted shares valued at $0, vesting on May 3, 2025.
  • This grant was issued in connection with services performed on the Value Enhancement Committee of the Board.
  • Following the transaction, Wolfe directly owns 88,839 shares of common stock.
  • Wolfe also holds options to buy 16,025 shares at $3.12, 4,132 shares at $12.1, and 16,806 shares at $5.95, all of which were exercisable as of the transaction date.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of a director's stock acquisition, which can be seen as a slightly positive sign of confidence, but it's not a major event.

Positives

  • The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates a director's continued involvement with the company through equity ownership.

Comparison to Industry Standards

  • Director share ownership is a common practice across publicly listed companies.
  • The size and structure of equity compensation packages vary widely based on company size, industry, and individual roles.
  • Comparing Wolfe's holdings and option grants to those of directors at peer companies like Logitech or Corsair could provide a benchmark for assessing the significance of this ownership.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders as it signals director alignment with company performance.

Key Dates

DateDescription
05/03/2024Date of transaction: Acquisition of 1,992 shares of common stock.
05/03/2025Vesting date for the 1,992 restricted shares.
04/11/2028Expiration date for stock options to buy 16,025 shares at $3.12.
04/01/2029Expiration date for stock options to buy 4,132 shares at $12.1.
04/01/2030Expiration date for stock options to buy 16,806 shares at $5.95.
05/07/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.